Lacosamide-associated second-degree atrioventricular block in a healthy, young athlete

Lacosamide enhances slow inactivation of voltage-gated sodium channels and can lead to dose-dependent PR interval prolongation. Previously, lacosamide has been associated with second-degree atrioventricular (AV) heart block in the context of multiple medical comorbidities and/or in the elderly with...

Full description

Bibliographic Details
Main Authors: Brian Stamm, Atif Sheikh, Stephan Schuele, Jessica W. Templer
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Epilepsy & Behavior Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589986420300204
_version_ 1818640285852237824
author Brian Stamm
Atif Sheikh
Stephan Schuele
Jessica W. Templer
author_facet Brian Stamm
Atif Sheikh
Stephan Schuele
Jessica W. Templer
author_sort Brian Stamm
collection DOAJ
description Lacosamide enhances slow inactivation of voltage-gated sodium channels and can lead to dose-dependent PR interval prolongation. Previously, lacosamide has been associated with second-degree atrioventricular (AV) heart block in the context of multiple medical comorbidities and/or in the elderly with multimorbidity on other dromotropic agents. We report a case of second-degree AV block occurring in a healthy, athletic young adult. The patient had baseline bradycardia with no known cardiac comorbidities. He was exquisitely sensitive to lacosamide with EKG and telemetry changes developing on the order of hours after receiving intravenous lacosamide. Lacosamide was subsequently stopped, the second-degree AV block was no longer present and EKG returned to baseline. We hypothesize that his sensitivity to lacosamide-induced AV block was possibly secondary to his baseline bradycardia with early repolarization changes. The case underscores the importance of surveillance cardiac monitoring. While medical comorbidities and an older age may portend a greater risk of PR prolongation, routine EKGs should be considered in all patients receiving lacosamide.
first_indexed 2024-12-16T23:08:51Z
format Article
id doaj.art-10a58375a2d44427b6576be213c4d0db
institution Directory Open Access Journal
issn 2589-9864
language English
last_indexed 2024-12-16T23:08:51Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series Epilepsy & Behavior Reports
spelling doaj.art-10a58375a2d44427b6576be213c4d0db2022-12-21T22:12:28ZengElsevierEpilepsy & Behavior Reports2589-98642020-01-0114100372Lacosamide-associated second-degree atrioventricular block in a healthy, young athleteBrian Stamm0Atif Sheikh1Stephan Schuele2Jessica W. Templer3Corresponding author at: Northwestern Memorial Hospital, 251 E Huron St, Chicago, IL 60611, United States.; Northwestern University Feinberg School of Medicine, Department of Neurology, Chicago, IL 60611, United StatesNorthwestern University Feinberg School of Medicine, Department of Neurology, Chicago, IL 60611, United StatesNorthwestern University Feinberg School of Medicine, Department of Neurology, Chicago, IL 60611, United StatesNorthwestern University Feinberg School of Medicine, Department of Neurology, Chicago, IL 60611, United StatesLacosamide enhances slow inactivation of voltage-gated sodium channels and can lead to dose-dependent PR interval prolongation. Previously, lacosamide has been associated with second-degree atrioventricular (AV) heart block in the context of multiple medical comorbidities and/or in the elderly with multimorbidity on other dromotropic agents. We report a case of second-degree AV block occurring in a healthy, athletic young adult. The patient had baseline bradycardia with no known cardiac comorbidities. He was exquisitely sensitive to lacosamide with EKG and telemetry changes developing on the order of hours after receiving intravenous lacosamide. Lacosamide was subsequently stopped, the second-degree AV block was no longer present and EKG returned to baseline. We hypothesize that his sensitivity to lacosamide-induced AV block was possibly secondary to his baseline bradycardia with early repolarization changes. The case underscores the importance of surveillance cardiac monitoring. While medical comorbidities and an older age may portend a greater risk of PR prolongation, routine EKGs should be considered in all patients receiving lacosamide.http://www.sciencedirect.com/science/article/pii/S2589986420300204EpilepsyPR prolongationLacosamideHeart blockArrhythmia
spellingShingle Brian Stamm
Atif Sheikh
Stephan Schuele
Jessica W. Templer
Lacosamide-associated second-degree atrioventricular block in a healthy, young athlete
Epilepsy & Behavior Reports
Epilepsy
PR prolongation
Lacosamide
Heart block
Arrhythmia
title Lacosamide-associated second-degree atrioventricular block in a healthy, young athlete
title_full Lacosamide-associated second-degree atrioventricular block in a healthy, young athlete
title_fullStr Lacosamide-associated second-degree atrioventricular block in a healthy, young athlete
title_full_unstemmed Lacosamide-associated second-degree atrioventricular block in a healthy, young athlete
title_short Lacosamide-associated second-degree atrioventricular block in a healthy, young athlete
title_sort lacosamide associated second degree atrioventricular block in a healthy young athlete
topic Epilepsy
PR prolongation
Lacosamide
Heart block
Arrhythmia
url http://www.sciencedirect.com/science/article/pii/S2589986420300204
work_keys_str_mv AT brianstamm lacosamideassociatedseconddegreeatrioventricularblockinahealthyyoungathlete
AT atifsheikh lacosamideassociatedseconddegreeatrioventricularblockinahealthyyoungathlete
AT stephanschuele lacosamideassociatedseconddegreeatrioventricularblockinahealthyyoungathlete
AT jessicawtempler lacosamideassociatedseconddegreeatrioventricularblockinahealthyyoungathlete